MXPA04003628A - Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them. - Google Patents
Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them.Info
- Publication number
- MXPA04003628A MXPA04003628A MXPA04003628A MXPA04003628A MXPA04003628A MX PA04003628 A MXPA04003628 A MX PA04003628A MX PA04003628 A MXPA04003628 A MX PA04003628A MX PA04003628 A MXPA04003628 A MX PA04003628A MX PA04003628 A MXPA04003628 A MX PA04003628A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutically acceptable
- compounds
- compositions containing
- benzoxazine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula I their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. More particularly, the present invention relates to novel alkyl carboxylic acids of the general, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. The present invention also relates to processes for the preparation of the compounds of formula I, novel intermediates, processes for their preparation, their use in the preparation of the above said compounds and their use as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN848MA2001 | 2001-10-16 | ||
| PCT/IB2002/004275 WO2003033481A1 (en) | 2001-10-16 | 2002-10-15 | Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04003628A true MXPA04003628A (en) | 2004-07-30 |
Family
ID=35824329
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04003629A MXPA04003629A (en) | 2001-10-16 | 2002-10-15 | Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds. |
| MXPA04003628A MXPA04003628A (en) | 2001-10-16 | 2002-10-15 | Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04003629A MXPA04003629A (en) | 2001-10-16 | 2002-10-15 | Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds. |
Country Status (9)
| Country | Link |
|---|---|
| KR (2) | KR20040048960A (en) |
| CN (1) | CN1982299A (en) |
| AU (1) | AU2002341289B2 (en) |
| CO (2) | CO5580819A2 (en) |
| MX (2) | MXPA04003629A (en) |
| NZ (1) | NZ532284A (en) |
| RS (2) | RS32404A (en) |
| RU (2) | RU2004111792A (en) |
| UA (1) | UA78522C2 (en) |
-
2002
- 2002-10-15 RU RU2004111792/04A patent/RU2004111792A/en not_active Application Discontinuation
- 2002-10-15 AU AU2002341289A patent/AU2002341289B2/en not_active Expired - Fee Related
- 2002-10-15 RS YUP-324/04A patent/RS32404A/en unknown
- 2002-10-15 KR KR10-2004-7005690A patent/KR20040048960A/en not_active Application Discontinuation
- 2002-10-15 NZ NZ532284A patent/NZ532284A/en unknown
- 2002-10-15 RS YU32304A patent/RS32304A/en unknown
- 2002-10-15 RU RU2004111786/04A patent/RU2004111786A/en not_active Application Discontinuation
- 2002-10-15 UA UA20040402821A patent/UA78522C2/en unknown
- 2002-10-15 CN CNA2006101562285A patent/CN1982299A/en active Pending
- 2002-10-15 MX MXPA04003629A patent/MXPA04003629A/en active IP Right Grant
- 2002-10-15 MX MXPA04003628A patent/MXPA04003628A/en active IP Right Grant
- 2002-10-15 KR KR10-2004-7005691A patent/KR20040052242A/en not_active Application Discontinuation
-
2004
- 2004-04-16 CO CO04035096A patent/CO5580819A2/en not_active Application Discontinuation
- 2004-04-16 CO CO04035089A patent/CO5580781A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5580781A2 (en) | 2005-11-30 |
| CN1982299A (en) | 2007-06-20 |
| NZ532284A (en) | 2006-02-24 |
| KR20040052242A (en) | 2004-06-22 |
| CO5580819A2 (en) | 2005-11-30 |
| RU2004111786A (en) | 2005-10-20 |
| RS32404A (en) | 2007-02-05 |
| UA78522C2 (en) | 2007-04-10 |
| MXPA04003629A (en) | 2004-07-30 |
| KR20040048960A (en) | 2004-06-10 |
| AU2002341289B2 (en) | 2008-07-24 |
| RS32304A (en) | 2006-12-15 |
| RU2004111792A (en) | 2005-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ504106A (en) | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them | |
| MY121760A (en) | Benzothiazin and benzoxazin derivatives;their preparation and uses | |
| HUP0401649A2 (en) | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them | |
| MXPA04005257A (en) | New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them. | |
| BG105925A (en) | Novel tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| WO1999008501A3 (en) | New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| MY140057A (en) | Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| YU52403A (en) | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them | |
| YU75101A (en) | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents | |
| HK1068877A1 (en) | Process for the production of beraprost and its salts | |
| BG106932A (en) | Novel compounds having hypolipedemic and hypocholesteremic activities, processes for their preparation and pharmaceutical compositions containing them | |
| MXPA03000161A (en) | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them. | |
| WO2005003087A3 (en) | Oxazole derivatives as antibacterial agents | |
| DE60114640D1 (en) | Antithrombosemittel | |
| EP0397511A3 (en) | Novel cephalosporin compounds and processes for preparation thereof | |
| UA72883C2 (en) | Bicyclic compounds, a method for preparing thereof and pharmaceutical compositions containing them | |
| MXPA04003628A (en) | Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them. | |
| CA2336380A1 (en) | Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof | |
| HK1037617A1 (en) | Process for the preparation of imidazodiazepine intermediates | |
| AU3678700A (en) | Process for the preparation of 3-hydroxytetrahydrofuran | |
| MXPA04002784A (en) | Pharmaceutically acceptable salts of 20(s)-camptothecins. | |
| MY136600A (en) | Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| HU9503718D0 (en) | Serotoninergic abeo-ergoline derivatives | |
| MX9601953A (en) | New compounds derived from 5h-tiazol[3,2-a]pyrimidin-5-one. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |